Skip to content

Lupin share price gains on USFDA approval for nasal spray

Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray.

Read More

​ Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray. Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish